Mounjaro side effects are most often mild to moderate gastrointestinal symptoms such as nausea, diarrhea, decreased appetite, and constipation. They tend to be worst in the first few weeks and right after each dose increase, then settle as your body adjusts. Serious problems are much less common, but a few red-flag symptoms need urgent medical care.
Mounjaro is the brand name for tirzepatide, a once-weekly injection approved for type 2 diabetes and used off-label for weight management. Its weight-approved twin is Zepbound. Tirzepatide is a dual GLP-1 and GIP receptor agonist, which is part of why it is so effective and also why it slows digestion enough to cause stomach-related side effects. For more on the mechanism, see how tirzepatide works, and for how it compares to its weight-loss counterpart, see Mounjaro vs Zepbound.
This article is informational only and reflects FDA labeling. It is not medical advice. Do not change or stop your dose on your own. Talk to the clinician who prescribed Mounjaro about any severe or persistent symptoms.
Why Mounjaro side effects follow the dose
Mounjaro is titrated slowly on purpose. You start at 2.5 mg once weekly for four weeks. This is a starter dose meant to reduce side effects, not a therapeutic dose. After four weeks you move to 5 mg, and from there your clinician can raise the dose in 2.5 mg steps at least four weeks apart, up to a maximum of 15 mg weekly.
The pattern most people notice is simple: symptoms tend to appear or intensify in the days right after each step up, then fade over the following weeks. That is exactly why titration is slow and steady. Many people have few symptoms at the 2.5 mg starter dose and more at higher doses. For a week-by-week picture, see our GLP-1 side effects timeline.
The reason for this pattern sits in how the medicine works. Tirzepatide slows how quickly the stomach empties, which helps you feel full sooner and eat less. Each time the dose goes up, that slowing effect becomes stronger before your body adapts to it. This is also why symptoms usually ease if you hold steady at a dose rather than climbing too fast. Your clinician may keep you at a lower dose for longer, or step back up more gradually, if a particular increase is hard to tolerate. That decision belongs with your prescriber, not something to do on your own.
What to expect by dose
| Dose (once weekly) | Role | What to expect |
|---|---|---|
| 2.5 mg | Starter dose (weeks 1-4), not therapeutic | Often well tolerated. Some mild nausea or reduced appetite as your body adjusts. |
| 5 mg | First maintenance dose | Nausea, mild diarrhea, or constipation may appear or increase in the first days, then ease. |
| 7.5-10 mg | Step-up doses | Gastrointestinal symptoms can return briefly after each increase. Appetite suppression is usually stronger. |
| 12.5-15 mg | Higher and maximum doses | At 15 mg in trials, roughly 18% reported nausea and about 17% reported diarrhea. Most cases were mild to moderate. |
The percentages above come from clinical trials and describe how many people reported a symptom over the whole study, not a guarantee of what any one person will feel. Many people at higher doses have only occasional, manageable symptoms.
Common Mounjaro side effects
The most common Mounjaro side effects are gastrointestinal and usually mild to moderate:
- Nausea - the most frequently reported symptom, often worst early or after a dose increase.
- Diarrhea - common and usually short-lived.
- Decreased appetite - expected and part of how the medicine works.
- Vomiting - less common than nausea but possible, especially early.
- Constipation - because digestion slows down.
- Indigestion and abdominal pain - a feeling of fullness, burping, or mild cramping.
How to manage Mounjaro side effects
Most gastrointestinal symptoms respond well to simple habits:
- Eat smaller, lower-fat meals and stop when you feel full.
- Eat slowly and avoid greasy or very rich foods that sit heavily.
- Stay well hydrated, especially if you have diarrhea or vomiting.
- Do not lie down right after eating.
- Give each dose step time; symptoms usually settle within a couple of weeks.
For targeted help, see our guides on managing nausea on GLP-1 and constipation on GLP-1. If nausea, vomiting, or diarrhea is severe or does not improve, contact your clinician rather than pushing through it.
What if side effects do not settle?
Most people find that gastrointestinal symptoms calm down within a couple of weeks at a given dose. When they do not, it is worth a conversation with your prescriber rather than a change you make alone. Options a clinician might consider include staying longer at the current dose before the next increase, adjusting the timing of the shot, or adding supportive measures for nausea or constipation. Persistent vomiting or diarrhea also raises the risk of dehydration, which is the usual cause of the acute kidney injury linked to these medicines, so it is not something to ignore. The goal is to find a dose you can live with while still getting the benefit, and that balance looks different for each person.
Serious and rare Mounjaro side effects
These are much less common than the stomach-related symptoms, but they matter. Contact a clinician promptly, and seek urgent or emergency care for the red flags noted below.
- Pancreatitis - inflammation of the pancreas. Severe, persistent abdominal pain, often radiating to the back and sometimes with vomiting, needs urgent care. See GLP-1 and pancreatitis.
- Gallbladder problems - including gallstones and cholecystitis, more likely with rapid weight loss. Learn more in GLP-1 and gallbladder.
- Acute kidney injury - usually a result of dehydration from ongoing vomiting or diarrhea, which is one reason hydration matters.
- Allergic reactions - rash, itching, swelling, or trouble breathing require emergency care.
- Worsening diabetic retinopathy - possible in some patients with existing eye disease; report vision changes.
- Low blood sugar - uncommon with Mounjaro alone, but more likely if you also take insulin or a sulfonylurea. Your clinician may adjust those medicines.
Boxed warning: thyroid tumors
Mounjaro carries a boxed warning for thyroid C-cell tumors based on rodent studies. Do not use Mounjaro if you have a personal or family history of medullary thyroid carcinoma or MEN2 (multiple endocrine neoplasia syndrome type 2). Report any lump or swelling in the neck, hoarseness, or trouble swallowing. See does GLP-1 cause thyroid cancer.
Muscle loss and hair shedding
Rapid weight loss itself can indirectly cause muscle loss and temporary hair shedding. These are not direct drug effects but consequences of losing weight quickly. Adequate protein intake and resistance training help protect muscle. See does GLP-1 cause muscle loss for practical steps.
When to get urgent care
Seek emergency or urgent medical care right away if you have any of these red-flag symptoms:
- Severe, persistent abdominal pain, especially if it spreads to your back.
- Signs of a serious allergic reaction: swelling of the face, lips, or throat, or trouble breathing.
- Vomiting or diarrhea that is severe or does not stop, or signs of dehydration such as dizziness and very little urine.
- Symptoms of very low blood sugar: shakiness, confusion, sweating, or fainting (more likely with insulin or a sulfonylurea).
- Sudden vision changes.
- A new lump or swelling in the neck.
Scientific References
3 sources- 1
Jastreboff AM, Aronne LJ, Ahmad NN, et al.
Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1)
New England Journal of Medicine · 387(3) · 2022PMID: 35658024
NEJM - 2
Drucker DJ
Mechanisms of Action and Therapeutic Application of Glucagon-like Peptide-1
Cell Metabolism · 27(4) · 2018PMID: 29617641
PubMed - 3
U.S. Food and Drug Administration
Prescribing information: Mounjaro (tirzepatide)
U.S. Food and Drug Administration · 2024
References open in a new tab. Content is reviewed against peer-reviewed literature as part of our editorial policy.
About the author
Modern Weight Science Editorial Team
Editorial Team
Evidence-based research and educational content focused on metabolism, appetite regulation, and sustainable weight management. Our team synthesizes peer-reviewed research into clear, accessible guidance for informed health decisions.
Every claim is checked against peer-reviewed research through our review process and fact-checking policy.
Frequently Asked Questions
What are the most common Mounjaro side effects?
The most common Mounjaro side effects are gastrointestinal: nausea, diarrhea, decreased appetite, vomiting, constipation, indigestion, and abdominal pain. Most cases are mild to moderate and improve as your body adjusts.
Do Mounjaro side effects get worse at higher doses?
Side effects tend to appear or intensify in the days right after each dose increase, then settle. That is why the dose is raised slowly in 2.5 mg steps at least four weeks apart. Many people have few symptoms at the 2.5 mg starter dose and more at higher doses.
How can I manage nausea on Mounjaro?
Eat smaller, lower-fat meals, eat slowly, stay hydrated, and avoid lying down right after eating. Symptoms usually ease within a couple of weeks. If nausea or vomiting is severe or persistent, contact your clinician.
What are the serious risks of Mounjaro?
Less common but serious risks include pancreatitis, gallbladder problems, acute kidney injury from dehydration, allergic reactions, and possible worsening of diabetic retinopathy. Mounjaro also carries a boxed warning for thyroid C-cell tumors based on rodent data.
Can Mounjaro cause low blood sugar?
Low blood sugar is uncommon with Mounjaro alone but more likely if you also take insulin or a sulfonylurea. Your clinician may adjust those medicines to lower the risk.
When should I seek urgent care while taking Mounjaro?
Get urgent care for severe or persistent abdominal pain, signs of a serious allergic reaction such as facial or throat swelling or trouble breathing, severe vomiting or diarrhea with dehydration, symptoms of very low blood sugar, sudden vision changes, or a new neck lump.
Continue learning
Where to read next
Not medical advice. This guide is for general education only. GLP-1 medications, dosing, and treatment suitability are decisions for you and a licensed clinician who knows your full medical history.